Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan/HCTZ vs Amlodipine in Essential Hypertension
NCT00426478Phase 4Completed
- Sponsor
- Novartis
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valsartan + hydrochlorothiazide in essential hypertension, sponsored by Novartis. Started Nov 2006; status: completed.
02
Drugs
valsartan + hydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00426478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00426478.